Showing results (821-830 of 96,490) with videos related to
Sort By:
Pageof 9,649
Nephron. Clinical Practice|May 17, 2008
Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patientsMasato Nishimura, Toshiko Tokoro, Masasya Nishida, et al.Allergology International : Official Journal of the Japanese Society of Allergology|February 27, 2014
Reference values for Japanese children's respiratory resistance using the LMS methodSatomi Hagiwara, Hiroyuki Mochizuki, Reiko Muramatsu, et al.Journal of the American Chemical Society|March 25, 2017
Solid-Solution Alloying of Immiscible Ru and Cu with Enhanced CO Oxidation ActivityBo Huang, Hirokazu Kobayashi, Tomokazu Yamamoto, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 1, 1997
Pulmonary hemosiderosis with hypersensitivity to buckwheatH Agata, N Kondo, O Fukutomi, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|August 26, 2010
Changes in cerebral oxygen saturation and blood flow during hypoxic gas ventilation therapy in HLHS and CoA/IAA complex with markedly increased pulmonary blood flowKentaro Toiyama, Kenji Hamaoka, Tatsujiro Oka, et al.Annals of Hematology|October 24, 2000
c-myc overexpression is not mandatory in aggressive-phase multiple myeloma with Burkitt's type translocationJ Kuroda, S Kimura, T Akaogi, et al.The American Journal of Pathology|December 7, 2000
Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectraT Hashimoto, Y Tokuchi, M Hayashi, et al.Indian Journal of Pediatrics|April 6, 2017
Rapidly progressive IgA nephropathyNaho Kobayashi, Masashi Nishida, Michiko Aoyama, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivoA Nishida, K Miyata, R Tsutsumi, et al.Studies in Health Technology and Informatics|October 4, 2007
A Japanese model of disease managementNaoki Nakashima, Kunihisa Kobayashi, Toyoshi Inoguchi, et al.Pageof 9,649